Last reviewed · How we verify
Reducing Antibiotics treatment duration — Competitive Intelligence Brief
phase 3
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Reducing Antibiotics treatment duration (Reducing Antibiotics treatment duration) — University of Oxford. This is a clinical trial strategy to optimize antibiotic treatment by reducing the duration of therapy while maintaining clinical efficacy and safety outcomes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Reducing Antibiotics treatment duration TARGET | Reducing Antibiotics treatment duration | University of Oxford | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Reducing Antibiotics treatment duration CI watch — RSS
- Reducing Antibiotics treatment duration CI watch — Atom
- Reducing Antibiotics treatment duration CI watch — JSON
- Reducing Antibiotics treatment duration alone — RSS
Cite this brief
Drug Landscape (2026). Reducing Antibiotics treatment duration — Competitive Intelligence Brief. https://druglandscape.com/ci/reducing-antibiotics-treatment-duration. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab